Illinois 104th General Assembly Status: Introduced Bipartisan · 22 D · 5 R cosponsors

SB2385      — PATIENT ACCESS 340B PHARMACY

Last action — Rule 3-9(a) / Re-referred to Assignments

  1. 1
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill has been introduced in the Senate. Introduced February 07, 2025. It must pass committee before a floor vote.

Next likely step: a committee referral and hearing.

Odds of enactment

Low chance

Based on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Advancing 34% · moderate confidence

  • Introduced

    Current position in the legislative process.

  • 27 sponsors

    1 primary, 26 co-sponsors signed on.

  • Bipartisan support

    Sponsored across 2 parties (22 D · 5 R) — cross-party backing.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Summary

Creates the Patient Access to Pharmacy Protection Act. Defines terms. Provides that no person, including a pharmaceutical manufacturer, may deny, restrict, prohibit, condition, or otherwise interfere with, either directly or indirectly, the acquisition of a 340B drug by, or delivery of a 340B drug to, a 340B covered entity or a 340B contract pharmacy authorized to receive 340B drugs on behalf of the 340B covered entity unless such receipt is prohibited by federal law. Provides that no person, including a pharmaceutical manufacturer, may impose any restriction on the ability of a 340B covered entity to contract with or designate a 340B contract pharmacy including restrictions relating to the number, location, ownership, or type of 340B contract pharmacy. Provides that no person, including a pharmaceutical manufacturer, may require or compel a 340B covered entity or 340B contract pharmacy to submit or otherwise provide ingredient cost or pricing data pertinent to 340B drugs unless required by State or federal law; institute requirements in any way relating to how a 340B covered entity manages its inventory of 340B drugs that are not required by a State or federal agency, including requirements relating to the frequency or scope of audits of inventory management systems of a 340B covered entity or a 340B contract pharmacy; or submit data or information that is not required by State or federal law as a condition for a 340B covered entity, its 340B contract pharmacy, or a location otherwise authorized by a 340B covered entity to receive 340B drugs. Sets forth provisions concerning enforcement of this Act; preemption of this Act; and severability of this Act. Effective immediately.

Bill Text

We don't have the full text on file for this bill yet.

Read SB2385 on the official Illinois source →

Action History

  1. Rule 3-9(a) / Re-referred to Assignments

  2. Senate Committee Amendment No. 1 Pursuant to Senate Rule 3-8(b-1), the following amendments will remain in the Committee on Assignments

  3. Rule 2-10 Committee/3rd Reading Deadline Established As June 1, 2025

  4. Senate Committee Amendment No. 1 Referred to Assignments

  5. Senate Committee Amendment No. 1 Filed with Secretary by Sen. David Koehler

  6. Added as Chief Co-Sponsor Sen. Willie Preston

  7. Rule 2-10 Committee/3rd Reading Deadline Established As May 23, 2025

  8. Added as Co-Sponsor Sen. Sally J. Turner

  9. Added as Co-Sponsor Sen. Sue Rezin

  10. Added as Co-Sponsor Sen. Robert Peters

  11. Added as Co-Sponsor Sen. Sara Feigenholtz

  12. Rule 2-10 Committee/3rd Reading Deadline Established As May 9, 2025

  13. Added as Co-Sponsor Sen. Laura M. Murphy

  14. Rule 2-10 Committee Deadline Established As April 11, 2025

  15. Added as Co-Sponsor Sen. Ram Villivalam

  16. Added as Chief Co-Sponsor Sen. Dale Fowler

  17. Added as Co-Sponsor Sen. Terri Bryant

  18. Added as Co-Sponsor Sen. Jil Tracy

  19. Rule 2-10 Committee Deadline Established As April 4, 2025

  20. Assigned to Executive

  21. Added as Chief Co-Sponsor Sen. Mattie Hunter

  22. Added as Co-Sponsor Sen. Steve Stadelman

  23. Added as Co-Sponsor Sen. Robert F. Martwick

  24. Added as Co-Sponsor Sen. Mike Simmons

  25. Added as Co-Sponsor Sen. Rachel Ventura

  26. Added as Co-Sponsor Sen. Kimberly A. Lightford

  27. Added as Co-Sponsor Sen. Mary Edly-Allen

  28. Added as Co-Sponsor Sen. Lakesia Collins

  29. Added as Co-Sponsor Sen. Patrick J. Joyce

  30. Added as Co-Sponsor Sen. Celina Villanueva

  31. Added as Co-Sponsor Sen. Paul Faraci

  32. Added as Co-Sponsor Sen. Mike Porfirio

  33. Added as Co-Sponsor Sen. Napoleon Harris III

  34. Added as Co-Sponsor Sen. Graciela Guzmán

  35. Added as Co-Sponsor Sen. Javier L. Cervantes

  36. Added as Co-Sponsor Sen. Michael W. Halpin

  37. Referred to Assignments

  38. First Reading

  39. Filed with Secretary by Sen. David Koehler

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 26 co-sponsors · 156 not signed on

Sponsors (1)

Co-sponsors (26)

Not signed on (156)

156 members have not signed on to this bill.

Show all 156 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SB2385      do?
Creates the Patient Access to Pharmacy Protection Act. Defines terms. Provides that no person, including a pharmaceutical manufacturer, may deny, restrict, prohibit, condition, or otherwise interfere with, either directly or indirectly, the acquisition of a 340B drug by, or delivery of a 340B drug to, a 340B covered entity or a 340B contract pharmacy authorized to receive 340B drugs on behalf of the 340B covered entity unless such receipt is prohibited by federal law. Provides that no person, including a pharmaceutical manufacturer, may impose any restriction on the ability of a 340B covered entity to contract with or designate a 340B contract pharmacy including restrictions relating to the number, location, ownership, or type of 340B contract pharmacy. Provides that no person, including a pharmaceutical manufacturer, may require or compel a 340B covered entity or 340B contract pharmacy to submit or otherwise provide ingredient cost or pricing data pertinent to 340B drugs unless required by State or federal law; institute requirements in any way relating to how a 340B covered entity manages its inventory of 340B drugs that are not required by a State or federal agency, including requirements relating to the frequency or scope of audits of inventory management systems of a 340B covered entity or a 340B contract pharmacy; or submit data or information that is not required by State or federal law as a condition for a 340B covered entity, its 340B contract pharmacy, or a location otherwise authorized by a 340B covered entity to receive 340B drugs. Sets forth provisions concerning enforcement of this Act; preemption of this Act; and severability of this Act. Effective immediately.
Who sponsors SB2385     ?
SB2385      is sponsored by David Koehler (Democrat), Mattie Hunter (Democrat), Dale Fowler (Republican), Willie Preston (Democrat), Michael W. Halpin (Democrat), Javier L. Cervantes (Democrat), Graciela Guzmán (Democrat), Napoleon Harris III (Democrat), Mike Porfirio (Democrat), Paul Faraci (Democrat), Celina Villanueva (Democrat), Patrick J. Joyce (Democrat), Lakesia Collins (Democrat), Mary Edly-Allen (Democrat), Kimberly A. Lightford (Democrat), Rachel Ventura (Democrat), Mike Simmons (Democrat), Robert F. Martwick (Democrat), Steve Stadelman (Democrat), Jil Tracy (Republican), Terri Bryant (Republican), Ram Villivalam (Democrat), Laura M. Murphy (Democrat), Sara Feigenholtz (Democrat), Robert Peters (Democrat), Sue Rezin (Republican), and Sally J. Turner (Republican).
What is the current status of SB2385     ?
This bill has been introduced in the Senate. Introduced February 07, 2025. It must pass committee before a floor vote.
Where can I track SB2385     ?
Track SB2385      free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB2385     

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SB2385     

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →